Kazia Therapeutics (KZIA) Other Non Operating Income (2009 - 2011)

Kazia Therapeutics (KZIA) posted Other Non Operating Income of -$140536.0 for Q4 2011, down 131.05% on a QoQ basis from $452626.6 in Q2 2010.

Kazia Therapeutics (KZIA) Other Non Operating Income (2009 - 2011) Analysis & Trends

Kazia Therapeutics' Other Non Operating Income history runs 3 years deep, the most recent figure standing at -$140536.0 for Q4 2011.

Quarterly Other Non Operating Income changed N/A year-over-year to -$140536.0 in Q4 2011, while the trailing twelve-month figure through Dec 2011 was -$451909.4 (changed N/A YoY) and the FY2013 annual result came in at -$389475.1, up 24.17% from the prior year.
Other Non Operating Income was -$140536.0 for Q4 2011 at Kazia Therapeutics, down from $452626.6 in the prior quarter.
Across five years, Other Non Operating Income topped out at $452626.6 in Q2 2010 and bottomed at -$362000.0 in Q4 2009.
A 3-year average of -$16636.5 and a median of -$140536.0 in 2011 frame the typical range for Other Non Operating Income.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn
7	Belite Bio	61.40 Bn	61.40 Bn	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn
9	Revolution Medicines	37.37 Bn	37.37 Bn	-
10	Kazia Therapeutics	19.25 Bn	19.25 Bn	-

Download Data